Please login to the form below
Pharmaceutical Market Europe (PME)
PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.
From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.
PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.
Merck & Co joins big pharma pricing pledge – but sceptics unconvinced
Large portfolios gives companies room for manoeuvre
Aurora partners with PIPHealth and taps into patient panels
Becomes the first strategic communications agency with its own patient panel
Daily brief: Novartis spends big on ezcema, Kite invests, another gene therapy IPO
A round up from pharma, biotech and healthcare
AstraZeneca joins Merck in Brexit stockpiling effort
Says it is increasing stores of medicines by around 20%
Articles
-
Malthus’ orphansFirms focusing on small, high-profit niches risk falling into a 200-year-old trap
-
Can new data aggregators shift the balance of power away from pharma? Making data a core competence
-
Trump attempts The Art of the Deal with pharmaYet incendiary language, bullying and threats rarely lead to a deal
-
Mylan sees the UK paving the way for an insulin game changerAs biosimilars surge into the insulin market, governments are urged to seize ‘the opportunity of the century’
-
Cutting through the noise
Why creativity = impact in medical education
Pharmaceutical Market Europe - June 2018
We start off looking at the newly released 2018 edition of the Drugs to Watch Report, with 12 blockbusters predicted to launch this year. There is hope that some of these new drugs may help patients who are dealing with several of the most unmanageable diseases.
Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app
Editor - Iona Everson
Have your say...
Subscribe
Healthcare Comms appointments
Cuttsy+Cuttsy appoints new director, Porterhouse Medical adds to team and TBWA\WorldHealth London sees Andy Hayley and Dick Dunford return
'Nothing about us without us'
Why patient engagement is essential throughout the entire product life cycle
Novartis launch NET cancer community app
Galaxies of Hope aims to provide support to cancer patients
Featured jobs
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Business Unit Head, Medical Communications, London
-
Excellent package
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
-
Client Services Director - Med Comms
-
Great salary and bebefits
-
Account Manager
-
£40, 000 - £45, 000 benefits
Subscribe to our email news alerts
- Brexit rebels win vote on European Medicines Agency alignment
- AstraZeneca joins Merck in Brexit stockpiling effort
- NHS England to Vertex: come clean on Orkambi offer
- Moving annual total (MAT)
- Vyriad inks immunotherapy alliance with Merck/Pfizer
- J&J’s Invokana aces diabetic kidney disease trial, setting up filings
- Random42 win Creativity International Award for Scientific Animation
- Merck & Co joins big pharma pricing pledge – but sceptics unconvinced
- Aurora partners with PIPHealth and taps into patient panels
- FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics
- Allergan’s abicipar matches AMD blockbuster Lucentis in phase III
- OUTiCO growth in multi-channel creates more job openings
PMHub
OPEN Access Consulting
OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
